Low level of antidepressant prescription for people who later commit suicide: 15 years of experience from a population‐based drug database in Sweden

Abstract

The use of antidepressants has been low in Jämtland County for many years, while the suicide rate has been among the highest in Sweden. A continuous outpatient prescription recording system has been in operation in Jämtland since 1970. Through this system we traced the prescription pattern of 80 individuals who committed suicide from 1970 to 1984. Suicide patients obtained 1.5 times more prescription drugs than 80 matched controls, mainly psychotropics and vitamins. During the 3 months prior to the suicide, half of the patients had received medical attention and 73% of the women and 40% of the men had obtained prescription drugs, in one-third from the psychiatric department. While 53% and 29%, respectively, obtained psychotropic drugs, only 13% and 9% respectively were prescribed antidepressants, often in low doses. People who will commit suicide often seek medical help. The low rate of antidepressant prescription in patients committing suicide probably reflects insufficient diagnosis and treatment of depressive disorders. It is urgent--for the individual as well as for society--that diagnostic and pharmacotherapeutic routines be improved.

Targeting suicide prevention to modifiable risk factors: has bipolar II been overlooked?

“…Furthermore, the perception of functional impairment, is often more critical in suicidality than the objective disability produced by disease (11,12), again testifying to the importance of depressive cognitions. ThatÕs why it is tragic that most individuals who commit suicide in the community had rarely received the benefit of adequate pharmacologic, psychotherapeutic or electroconvulsive treatment for depression (13)(14)(15)(16).…”

Données récentes d’études scandinaves. Traiter la dépression : une stratégie efficace de prévention du suicide?

“…Contexte L'étude présentée par le premier auteur est l'aboutissement d'une série d'autres études (Isacsson et al, 1992 ;1994a ;1994b ;1996a ;1996b ;Rich et Isacsson, 1997). Cette série d'études menées au début des années quatre-vingt-dix par le premier auteur en collaboration avec des collègues suédois et américains a montré ce qui suit.…”

L’utilisation clinique des benzodiazépines pour le traitement de l’anxiété : Où en sommes-nous?

“…Contexte L'étude présentée par le premier auteur est l'aboutissement d'une série d'autres études (Isacsson et al, 1992 ;1994a ;1994b ;1996a ;1996b ;1999 ;2000 ;Rich et Isacsson, 1997). Cette série d'études menées au début des années quatre-vingt-dix par le premier auteur en collaboration avec des collègues suédois et américains a montré ce qui suit.…”